These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 5835700)
1. Genetic information used during synthesis of virus components and antivirus immunity. Mekler LB Nature; 1965 Apr; 206(982):343-6. PubMed ID: 5835700 [No Abstract] [Full Text] [Related]
2. The source of self: genetic parasites and the origin of adaptive immunity. Villarreal LP Ann N Y Acad Sci; 2009 Oct; 1178():194-232. PubMed ID: 19845639 [TBL] [Abstract][Full Text] [Related]
3. [Inactivation in vitro of the Rous sarcoma virus by an isolated mucopolysaccharide of the sarcoma ascites]. GOLDE A; VIGIER P Ann Inst Pasteur (Paris); 1959 Aug; 97():227-33. PubMed ID: 13850616 [No Abstract] [Full Text] [Related]
4. The significance of lymph and other elements of the lymphatic system in antivirus immunity. GAIDAMOVICH SY; SOLOVIEV VD Am Rev Sov Med; 1947 Feb; 4(3):226-30. PubMed ID: 20285210 [No Abstract] [Full Text] [Related]
5. Macrophages and viral immunity. Silverstein S Semin Hematol; 1970 Apr; 7(2):185-214. PubMed ID: 4317324 [No Abstract] [Full Text] [Related]
6. A new in vitro method (END) for detection and measurement of hog cholera virus and its antibody by means of effect of HC virus on Newcastle disease virus in swine tissue culture. I. Establishment of standard procedure. KUMAGAI T; SHIMIZU T; IKEDA S; MATUMOTO M J Immunol; 1961 Sep; 87():245-56. PubMed ID: 13755081 [No Abstract] [Full Text] [Related]
7. A new in vitro method (END) for detection and measurement of hog cholera virus and its antibody by means of effect of HC virus on Newcastle disease virus in swine tissue culture. II. Some characteristics of END method. MATUMOTO M; KUMAGAI T; SHIMIZU T; IKEDA S J Immunol; 1961 Sep; 87():257-68. PubMed ID: 13768332 [No Abstract] [Full Text] [Related]
16. [Cross immunity tests between RH strains of Toxoplasma gondii and its associated filterable virus]. Fabio U; Provvisionato CA; Olivo R G Batteriol Virol Immunol Ann Osp Maria Vittor Torino; 1971; 64(5):173-8. PubMed ID: 5004723 [No Abstract] [Full Text] [Related]
18. Immune interferon: some properties and functions. Baron S; Blalock JE; Dianzani F; Fleischmann WR; Georgiades JA; Johnson HM; Stanton GJ Ann N Y Acad Sci; 1980; 350():130-44. PubMed ID: 6165268 [No Abstract] [Full Text] [Related]
19. Production of mutations in tobacco mosaic virus by chemical treatment of its nucleic acid in vitro. MUNDRY KW; GIERER A Z Vererbungsl; 1958; 89(4):614-30. PubMed ID: 13604838 [No Abstract] [Full Text] [Related]
20. [Immunity of viruses and the effectiveness of vaccines. Mode of virus infections and effectiveness of vaccines]. Shishido A Nihon Rinsho; 1987 Oct; 45(10):2218-24. PubMed ID: 3448260 [No Abstract] [Full Text] [Related] [Next] [New Search]